PureTech Health (PRTC) Shares Outstanding (Weighted Average) (2019 - 2025)
PureTech Health (PRTC) reported Shares Outstanding (Weighted Average) of $4.9 million for Q4 2025, down 98.09% year-over-year from $254.5 million in Q4 2024, and little changed on a QoQ basis from $4.9 million in Q2 2025.
PureTech Health (PRTC) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $4.9 million in Q4 2025.
- Quarterly Shares Outstanding (Weighted Average) fell 98.09% year-over-year to $4.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.9 million (down 98.09% YoY) and the FY2025 annual result came in at $4.9 million, down 98.09% from the prior year.
- Shares Outstanding (Weighted Average) held at $4.9 million in Q4 2025 per PRTC's latest filing, from $4.9 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $287.8 million in Q4 2021 and bottomed at $4.9 million in Q2 2025.
- The 5-year median for Shares Outstanding (Weighted Average) is $130.0 million (2023), against an average of $139.3 million.
- The widest annual swing landed in 2024, when Shares Outstanding (Weighted Average) soared 4559.52%; it then sank 98.09% in 2025.
- Tracing PRTC's Shares Outstanding (Weighted Average) over 5 years: stood at $287.8 million in 2021, then decreased by 3.21% to $278.6 million in 2022, then slumped by 98.04% to $5.5 million in 2023, then soared by 4559.52% to $254.5 million in 2024, then slumped by 98.09% to $4.9 million in 2025.
- Per Business Quant, the three latest PRTC Shares Outstanding (Weighted Average) figures stand at $4.9 million (Q4 2025), $4.9 million (Q2 2025), and $254.5 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 177,333.76 Bn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 185,491.37 Bn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 100.00 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 55.66 Bn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 254.10 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 104.00 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 16.04 Bn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 132.89 Mn |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | 4.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.86 Mn |
| Jun 30, 2025 | 4.86 Mn |
| Dec 31, 2024 | 254.46 Mn |
| Dec 31, 2023 | 5.46 Mn |
| Dec 31, 2022 | 278.57 Mn |
| Dec 31, 2021 | 287.80 Mn |
| Dec 31, 2020 | 285.89 Mn |
| Dec 31, 2019 | 285.37 Mn |